Skip to content
Search

Latest Stories

Prednisolone 1mg Gastro-Resistant Tabs is now available in pot of 100 tablets

Shilpa Sharma
By Shilpa SharmaFeb 17, 2022
Shilpa Sharma
See Full Bio

Following some manufacturing challenges, Phoenix Labs has changed the packaging of Prednisolone 1mg Gastro-Resistant tablets to a pot of 100 tablets from a blister pack of 30 tablets earlier.

The old blister packs of 30 tablet having an expiry date of April 2022 will be discontinued once the existing stock is sold out, a spokesperson from the company said on Wednesday (February 17).

The medication in new packs will be available from AAH, Alliance Healthcare and Phoenix Medical.

Prednisolone is used for a wide variety of diseases. Some of the principal indications include respiratory disorder, severe hypersensitivity reactions, anaphylaxis and severe skin conditions.

Phoenix Labs, which holds marketing authorisation for Prednisolone 1mg Gastro-Resistant tablets, is an integrated healthcare company operating in the prescription and OTC market segments.

prednisolonemedicine

Related News

Operation Subaru:
News

12 arrested in MHRA’s biggest medicines trafficking crackdown

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair
News

Olivier Picard named new NPA chair

RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care
News

Professor Tony Avery OBE awarded RPS Honorary Fellowship

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.
News

Pharma sector needs protecting from Trump tariffs, warn MPs

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc